Literature DB >> 31525623

Examining the link between dose-dependent dietary iron intake and Alzheimer's disease through oxidative stress in the rat cortex.

Hamid Ceylan1, Harun Budak2, Enver Fehim Kocpinar3, Nurdan Gonul Baltaci2, Orhan Erdogan2.   

Abstract

BACKGROUND: Neurodegenerative diseases such as Alzheimer's and Parkinson's disease are characterized by the progressive deterioration of the structure and function of the nervous system. A number of environmental risk factors including potentially toxic elements such as iron, lead to negative effects on many metabolic reactions as well as neuroprotection. The aim of this study is to reveal whether long-term iron overload is one of the underlying factors in the pathogenesis of Alzheimer's disease (AD).
METHODS: 15 young-adult male rats were randomly divided into 5 groups treated with iron through drinking water for 4 months. Following feeding, the iron content, reduced glutathione (GSH), and hydrogen peroxide (H2O2) levels of cortex tissues were measured. Specific enzyme activities were determined spectrophotometrically. mRNA expression profiles were measured using real-time PCR (qPCR).
RESULTS: Iron levels were elevated in case of non-toxic (0.87 and 3 μg/mL) iron administration. However, no changes were observed in toxic (30 and 300 μg/mL) iron administration. GSH and H2O2 levels altered with long-term iron overload. Glutathione peroxidase (GPx) enzyme activities significantly increased in all groups, while glutathione S-transferase (GST) activity increased only in case of 0.87 and 30 μg/mL iron administration. Expression levels of neuroprotective and AD-related genes were altered by 3 μg/mL iron overload in a dose-dependent manner. The expression and activity of acetylcholinesterase (AChE) were elevated at 3 μg/mL iron concentration.
CONCLUSION: The findings of the present study allow us to conclude that long-term dietary iron intake, especially at a dose of 3 μg/mL demonstrates negative effects on the rat cortex by provoking antioxidant metabolism and AD pathology in a dose-dependently.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Neurotoxicity; Oxidative stress; Rat cortex; Toxic element

Year:  2019        PMID: 31525623     DOI: 10.1016/j.jtemb.2019.09.002

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  6 in total

1.  Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer's Disease: Insights from a Synaptic Machinery Perspective.

Authors:  Hamid Ceylan
Journal:  J Mol Neurosci       Date:  2021-08-19       Impact factor: 3.444

2.  Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation.

Authors:  Nurdan Gönül Baltacı; Emine Toraman; Mesut Akyüz; Şeyda Nur Kalın; Harun Budak
Journal:  Biometals       Date:  2022-08-20       Impact factor: 3.378

3.  In Vitro Anticancer Activity of Novel Co(II) and Ni(II) Complexes of Non-steroidal Anti-inflammatory Drug Niflumic Acid Against Human Breast Adenocarcinoma MCF-7 Cells.

Authors:  Sema Caglar; Ahmet Altay; Mehmet Kuzucu; Bulent Caglar
Journal:  Cell Biochem Biophys       Date:  2021-04-29       Impact factor: 2.194

Review 4.  Astrocytes in heavy metal neurotoxicity and neurodegeneration.

Authors:  Baoman Li; Maosheng Xia; Robert Zorec; Vladimir Parpura; Alexei Verkhratsky
Journal:  Brain Res       Date:  2021-01-05       Impact factor: 3.252

Review 5.  Alzheimer's disease treatment: The share of herbal medicines.

Authors:  Masoud Soheili; Mohammad Karimian; Gholamali Hamidi; Mahmoud Salami
Journal:  Iran J Basic Med Sci       Date:  2021-02       Impact factor: 2.699

6.  Radical Scavenging Activity and Pharmacokinetic Properties of Coumarin-Hydroxybenzohydrazide Hybrids.

Authors:  Marko R Antonijević; Edina H Avdović; Dušica M Simijonović; Žiko B Milanović; Ana D Amić; Zoran S Marković
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.